The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study
- Supplementary File 1:
PDF-Document (PDF, 237 KiB)
Khan, P.; Riberto, M.; Frances, J.A.; Chueire, R.; Amorim, A.C.F.G.; Xerez, D.; Chung, T.M.; Mercuri, L.H.C.; Longo, A.L.; Lianza, S.; Maisonobe, P.; Ruiz-Schutz, V.C. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study. Toxins 2020, 12, 770. https://doi.org/10.3390/toxins12120770
Khan P, Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Longo AL, Lianza S, Maisonobe P, Ruiz-Schutz VC. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study. Toxins. 2020; 12(12):770. https://doi.org/10.3390/toxins12120770
Chicago/Turabian StyleKhan, Patricia; Riberto, Marcelo; Frances, João A.; Chueire, Regina; Amorim, Ana C.F.G.; Xerez, Denise; Chung, Tae M.; Mercuri, Lucia H.C.; Longo, Alexandre L.; Lianza, Sérgio; Maisonobe, Pascal; Ruiz-Schutz, Viviane C. 2020. "The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study" Toxins 12, no. 12: 770. https://doi.org/10.3390/toxins12120770